Cargando…
Insights into the actions of angiotensin-1 receptor (AT1R) inverse agonists: Perspectives and implications in COVID-19 treatment
New coronavirus SARS-CoV-2 (COVID-19) has caused chaos in health care systems. Clinical manifestations of COVID-19 are variable, with a complex pathophysiology and as yet no specific treatment. It has been suggested that the renin-angiotensin-aldosterone system has a possible role in the severity of...
Autores principales: | Heimfarth, Luana, dos Santos, Mario Adriano, Barreto-Filho, José Augusto, Barreto, André Sales, Macedo, Fabrício Nunes, Araújo, Adriano Antunes de Souza, Martins-Filho, Paulo, Scotti, Marcus Tullius, Scotti, Luciana, Quintans-Júnior, Lucindo José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898045/ https://www.ncbi.nlm.nih.gov/pubmed/33628162 http://dx.doi.org/10.17179/excli2021-3412 |
Ejemplares similares
-
Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020) -
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2021) -
Drug repurposing and cytokine management in response to COVID-19: A review
por: Heimfarth, Luana, et al.
Publicado: (2020) -
Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity
por: Rocha Santos Passos, Fabiolla, et al.
Publicado: (2022) -
ChatGPT: the new panacea of the academic world
por: Quintans-Júnior, Lucindo José, et al.
Publicado: (2023)